Electroacupuncture Relieves Nerve Injury–Induced Pain Hypersensitivity via the Inhibition of Spinal P2X7 Receptor–Positive Microglia

    loading  Checking for direct PDF access through Ovid



Electroacupuncture (EA) has therapeutic effects on neuropathic pain induced by nerve injury; however, the underlying mechanisms remain unclear. In this study, we examined whether EA treatment relieves pain hypersensitivity via the down-regulation of spinal P2X7 receptor–positive (P2X7R+) microglia-mediated overexpression of interleukin (IL)-1β and/or IL-18.


Male Sprague-Dawley rats underwent chronic constriction injury (CCI) or 3′-O-(4-benzoylbenzoyl) adenosine 5′-triphosphate (BzATP) intrathecal injection. Von Frey and Hargreaves tests were performed to evaluate the effect of EA on pain hypersensitivity. The spinal P2X7R, IL-1β, and IL-18 expression levels were determined by real-time polymerase chain reaction, Western blot analysis, immunofluorescence staining, and enzyme-linked immunosorbent assay. The selective P2X7R antagonist A-438079 was used to examine the P2X7R+ microglia–dependent release of IL-1β and IL-18. Primary cultures were subsequently used to assess the P2X7R+ microglia–induced IL-1β and IL-18 release.


EA treatment significantly improved the pain thresholds and inhibited spinal P2X7R+ microglia activation induced by CCI or BzATP administration, which was accompanied by the suppression of spinal IL-1β and IL-18 overexpression. Moreover, A-438079 also improved pain thresholds and suppressed overexpression of IL-1β in the CCI- and BzATP-injected rats. The analysis of cultured microglia further demonstrated that A-438079 markedly decreased BzATP-induced IL-1β release.


EA treatment relieves nerve injury-induced tactile allodynia and thermal hyperalgesia via the inhibition of P2X7R+ microglia–mediated IL-1β overexpression.

Related Topics

    loading  Loading Related Articles